SARS-COV-2 Vaccinations in RMD patients
The EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021).
The information addresses questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs.
EULAR President, Prof Annamaria Iagnocco, invites you to share the link with your axSpA community.
Other NEWS

Building a Partnership with Your Doctor
“The partnership you develop with your doctor will be very …
Read More
The psychological burden of axSpA and the support patient organisations’ can offer to their members
It is becoming clearer that depression and anxiety are prominent …
Read More